View Clinical Trial (Medical Research Study)

Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes - NCT00992914-60611(Clinical Trial 368661)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Chicago
State:  
IL
Zip Code: 60611
Conditions: Hot Flashes - Menopause
Purpose: This study is being done to determine whether stellate ganglion injection with local anesthetic (the study procedure) can reduce the number and severity of hot flashes in women who have hot flashes. Hot flashes can have a significant impact on daily living, disrupt sleep, and lead to fatigue and irritability during the day. Hot flashes are the most common reason that women seek hormonal therapy. However, for many women, including breast cancer survivors, this is rarely an option, and these women seek alternatives to hormonal therapy to treat hot flashes. The study procedure has been in clinical use for more than fifty years in treating certain disease states and chronic pain. The study procedure has not been used to relieve hot flashes and the use of the study procedure with local anesthetic for the reduction of hot flushes is considered experimental.
Study summary:
Criteria: Inclusion Criteria: - Women surgically or naturally menopausal, - Experiencing moderate to severe hot flushes, AND - Elect to undergo stellate ganglion block procedure. Exclusion Criteria: - Subjects who are currently sick, - Subjects have acute infections or cardiac compromise, - Subjects who have local infections of the anterior neck region, severe - Subjects who have pulmonary disease, - Subjects who are anticoagulated, - Subjects who are on hormone therapy, - Subjects who have a blood clotting disorder, - Subjects who have an American Society of Anesthesiologists (ASA) physical status score of 3 or higher (severe systemic disease, not incapacitating), - Subjects who have allergic reactions to local anesthetics and/or contrast dyes, - Subjects who have past or present diagnosis of psychosis, - Subjects who have current diagnosis of depression, OR - Subjects who have current substance or alcohol abuse.
Study is available at: Northwestern University
Chicago, IL 60611
United States

Primary Contact:
Suzanne Banuvar, MPA/HSA
Email: sbanuvar@nmh.org
Phone: 312-926-6631
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.